Pei H. Luo

QSAR Pharmacophore-based Virtual Screening, CoMFA and CoMSIA Modeling and Molecular Docking towards Identifying Lead Compounds for Breast Cancer Protease Inhibitors

Lan Huang, Xuan R. Zhang, Pei H. Luo, Lun Yuan, Xang Z. Zhou, X. Gao & Ling S. Li · Journal of Pharmaceutical Research International · 2017

Aim: This study used QSAR Pharmacophore-based virtual screening and molecular docking to identify lead compounds and determine structural requirements for breast cancer inhibitor development. CoMFA and CoMSIA modeling was employed to design more potential inhibitors. Materials an...

Open access Research Article 10.9734/JPRI/2017/37821

Identifying Potential Dual Inhibitory Candidates for Non-Small Cell Lung Cancer through Molecular Docking, 3D-QSAR Pharmacophore-based Virtual Screening, Comparative Molecular Field and Similarity Indices Analysis Modeling

Xiao X. Zhu, Yan Li, Xuan R. Zhang, Lun Yuan, Pei H. Luo, X. Gao & Zhong S. Tan · Journal of Pharmaceutical Research International · 2018

Aim: This work aims to understand potential inhibitory structural requirements and identify lead compounds for non-small cell lung cancer through 3D-QSAR pharmacophore-based virtual screening, molecular docking, CoMSIA and CoMFA QSAR modelling. Materials and Methods: QSAR pharmac...

Open access Research Article 10.9734/JPRI/2018/44771